Neuronetics, Inc.

NASDAQ:STIM

0.94 (USD) • At close September 18, 2024
Bedrijfsnaam Neuronetics, Inc.
Symbool STIM
Munteenheid USD
Prijs 0.945
Beurswaarde 28,623,188
Dividendpercentage 0%
52-weken bereik 0.664 - 5.07
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Keith J. Sullivan
Website https://www.neurostar.com

An error occurred while fetching data.

Over Neuronetics, Inc.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System

Vergelijkbare Aandelen

ImmuCell Corporation logo

ImmuCell Corporation

ICCC

3.6 USD

Mustang Bio, Inc. logo

Mustang Bio, Inc.

MBIO

0.254 USD

Silver Spike Investment Corp. logo

Silver Spike Investment Corp.

SSIC

11.74 USD

Great Elm Group, Inc. logo

Great Elm Group, Inc.

GEG

1.88 USD

LifeMD, Inc. logo

LifeMD, Inc.

LFMD

5.24 USD

Curis, Inc. logo

Curis, Inc.

CRIS

5.86 USD

SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc.

SLS

1.22 USD

Cyteir Therapeutics, Inc. logo

Cyteir Therapeutics, Inc.

CYT

3.02 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)